[go: up one dir, main page]

CR20130401A - INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT - Google Patents

INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT

Info

Publication number
CR20130401A
CR20130401A CR20130401A CR20130401A CR20130401A CR 20130401 A CR20130401 A CR 20130401A CR 20130401 A CR20130401 A CR 20130401A CR 20130401 A CR20130401 A CR 20130401A CR 20130401 A CR20130401 A CR 20130401A
Authority
CR
Costa Rica
Prior art keywords
nsaid
inflammatory
mastitis
antibiotic
injectable compositions
Prior art date
Application number
CR20130401A
Other languages
Spanish (es)
Inventor
Fadil Al Alawi
Wayne Frederick Leech
Karthigeyan Nanjan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46515931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130401(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of CR20130401A publication Critical patent/CR20130401A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto inyectable cuando se utiliza para el tratamiento de una infección microbiana en una glándula mamaria de un animal, en el que el compuesto incluye a) un fármaco antinflamatorio no esteroide (AINE)An injectable compound when used for the treatment of a microbial infection in an mammary gland of an animal, in which the compound includes a) a non-steroidal anti-inflammatory drug (NSAID)

CR20130401A 2011-01-20 2013-08-19 INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT CR20130401A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ588686A NZ588686A (en) 2011-01-20 2011-01-20 Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland

Publications (1)

Publication Number Publication Date
CR20130401A true CR20130401A (en) 2014-02-04

Family

ID=46515931

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130401A CR20130401A (en) 2011-01-20 2013-08-19 INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT

Country Status (16)

Country Link
KR (1) KR101905173B1 (en)
CN (1) CN103327984B (en)
AU (1) AU2012207698A1 (en)
BR (1) BR112013018557B1 (en)
CL (1) CL2013002086A1 (en)
CO (1) CO6801732A2 (en)
CR (1) CR20130401A (en)
GT (1) GT201300182A (en)
IL (1) IL227540A (en)
MX (1) MX353876B (en)
NI (1) NI201300063A (en)
NZ (1) NZ588686A (en)
PE (1) PE20140035A1 (en)
PH (1) PH12013501449A1 (en)
WO (1) WO2012099479A1 (en)
ZA (1) ZA201305780B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2995297A1 (en) * 2014-09-09 2016-03-16 Ceva Sante Animale Parenteral compositions and uses thereof
AR102172A1 (en) 2015-10-05 2017-02-08 Química Luar S R L A BACTERICIDE AND VIRUCIDE PHARMACEUTICAL COMPOSITION
CN105663037A (en) * 2016-01-27 2016-06-15 成都乾坤动物药业有限公司 Amoxicillin solution as well as preparation method and application thereof
CN112472667B (en) * 2019-08-23 2022-11-15 北京欧博方医药科技有限公司 Retxib long-acting injection and preparation method and application thereof
CN111035614B (en) * 2019-12-20 2024-02-02 北京喜禽药业有限公司 High-content terramycin injection and preparation method thereof
US12324853B2 (en) 2020-08-10 2025-06-10 Quimica Luar S.R.L. Methods for treating respiratory viral infections
PE20231034A1 (en) * 2023-04-05 2023-07-10 Agrovet Market S A INJECTABLE PHARMACEUTICAL COMPOSITION INCLUDING TILVALOSIN TARTRATE AND ITS METHOD OF MANUFACTURING

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CN1297319C (en) * 2003-09-22 2007-01-31 王玉万 Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
WO2005044254A1 (en) * 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
DE102004025324A1 (en) * 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation for veterinary medicine, process for their preparation and their use

Also Published As

Publication number Publication date
NZ588686A (en) 2013-07-26
IL227540A (en) 2017-12-31
BR112013018557A2 (en) 2016-11-22
IL227540A0 (en) 2013-09-30
NI201300063A (en) 2014-05-23
WO2012099479A1 (en) 2012-07-26
PH12013501449A1 (en) 2013-08-28
MX353876B (en) 2018-02-01
PE20140035A1 (en) 2014-02-16
CN103327984A (en) 2013-09-25
MX2013008407A (en) 2013-09-26
ZA201305780B (en) 2014-04-30
CO6801732A2 (en) 2013-11-29
BR112013018557B1 (en) 2021-11-03
KR20140012646A (en) 2014-02-03
GT201300182A (en) 2014-07-28
CL2013002086A1 (en) 2014-07-25
CN103327984B (en) 2016-08-17
AU2012207698A1 (en) 2013-04-18
KR101905173B1 (en) 2018-11-28

Similar Documents

Publication Publication Date Title
CR20130401A (en) INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT
CL2008000418A1 (en) Use of an il-23 antagonist for the treatment of a fungal infection.
BR112014000665A2 (en) compound, use thereof, pharmaceutical composition, antimicrobial agent, and method for preventing or treating a bacterial infection
ES2527242T3 (en) Compositions comprising a germinant and an antimicrobial agent
MX2013000567A (en) PHARMACEUTICAL COMPOSITIONS OF C-MET MODULATORS.
MX2021003230A (en) PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM.
CL2011001389A1 (en) Isoxazoline derivative compounds; composition comprising one of the compounds; and use of the compounds in parasite control.
CR20120418A (en) VIRUS FLAVIVIRIDAE INHIBITORS
CL2009000426A1 (en) Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections
EA201000775A1 (en) BETA LACTAMASE INHIBITORS
CR20140231A (en) ACETIC BENZOTIAZOL-6-IL ACID DERIVATIVES AND THEIR USE TO TREAT AN HIV INFECTION
CL2013003287A1 (en) Compounds derived from 5-trifluoromethyl-4,5-dihydro-isoxazole; intermediate compounds; preparation procedure; pharmaceutical compositions comprising them; and use in the treatment of a parasite infestation in animals.
CY1118250T1 (en) CERTAIN TRIAZOLOPYRAZINS, THEIR COMPOSITIONS AND METHODS FOR USE
CR20140450A (en) COMPOSITION FOR PEST CONTROL THAT INCLUDES A NEW IMINOPIRIDINE DERIVATIVE
MD4577B1 (en) Chewable compositions for veterinary use containing an isoxazoline active agent and their use for the treatment or prevention of parasitic infestation or infection
CR11626A (en) BETA-LACTAMASA INHIBITORS
MX385616B (en) CDK INHIBITORS
MX2015012576A (en) COMPOSITIONS BASED ON NANOPARTICLES.
CL2015002755A1 (en) Antibiotic compositions of ceftolozano.
BR112014025041B8 (en) PHARMACEUTICAL COMPOSITION
CL2011000258A1 (en) Compounds derived from phenylamino-isonicotinamide; mek inhibitors; Pharmaceutical composition and use for the treatment of hyperproliferative diseases such as cancer and inflammation.
CL2015002253A1 (en) Pharmaceutical compositions for the treatment of helicobacter pylori.
CL2008001728A1 (en) Compounds derived from indolinones; pharmaceutical composition comprising said compound; and use of the compound for the treatment of cancer, infections, inflammatory and autoimmune diseases.
CL2009000294A1 (en) Compounds derived from aryl methylidene heterocycles; pharmaceutical composition comprising them; and use in the treatment of neuropathic pain and inflammation.
GT201300225A (en) TIENO (2,3-D) DERIVED FROM PIRIMIDINE AND ITS USE FOR THE TREATMENT OF ARRITMIA